Focus research 2022 RADOPT team
Metabolic shift & radioresistance
The MSrGB (Metabolic Shift in radioresistance of Glioblastoma) project, which is coordinated by Prof. Elizabeth Moyal and accredited by the Fondation ARC (PGA) in 2022, aims to study the involvement of metabolic shift in glioblastoma stem cells in adaptation and resistance to radiotherapy. In addition to the RADOPT team, this program involves the IUCT-Oncopole, as well as Prof. Tourneret’s team at IRIT, where new metabolites and their ability to predict relapse after treatment will be identified and studied using deep learning. To find out more
To find out more about the IUCT-Oncopole and CRCT-Oncopole research focuses, please click here.
Centre de Recherches contre le Cancer de Toulouse (Oncopole)
Toulouse - FR
CRCT-Oncopole Follow 1,220 1,117
Compte officiel du Centre de Recherches en Cancérologie de Toulouse
;
Castelnau-Montratier célèbre la lutte contre le cancer. Jeudi 24 août 2023 conférence avec Frédéric Chibon responsable de l'équipe @OncoSarc du @crctoncopole accompagné de Gwenaël Ferron et Martin Gauthier oncologue @IUCTOncopole
Découvrir l'équipe
➡️https://www.crct-inserm.fr/oncosarc/
Nous contacter
+33 5 82 74 15 75
Nous rejoindre ?
